共 34 条
[3]
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: An update of the initial randomized study population and data of additional patients treated with the same regimen
[J].
CLINICAL CANCER RESEARCH,
2007, 13 (01)
:228-233
[4]
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (16)
:3676-3685
[9]
Dixon W.J., 1983, Introduction to Statistical Analysis, V4th